ArticleNucleic acids research2026
LnCeVar 2.0: an updated resource and web tools for genomic variations disrupting ceRNA networks from single-cell/spatial transcriptomics data.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
LnCeVar 2.0 (available at http://bio-bigdata.hrbmu.edu.cn/LnCeVar or http://www.bio-bigdata.net/LnCeVar) is an updated database investigating genomic variations that disrupt competing endogenous RNA (ceRNA) networks via single-cell and spatial transcriptomics. Enhancements include expanded data and improved features: (i) 16 937 experimentally supported cancer biomarkers as well as 5785 validated ceRNA interactions and single nucleotide variant (SNV)-ceRNA events, manually curated and linked to key cancer pathogenic processes; (ii) 812 single-cell RNA sequencing/spatial transcriptomics RNA sequencing datasets covering 102 diseases, clinical treatments (e.g. chemotherapy, immunotherapy), and normal tissues; (iii) 5 218 062 single-cell- and spatial-specific SNV-ceRNA events across 2 673 603 cells/spots, with cellular functional perturbation networks; (iv) 5 comprehensive and 12 mini tools for multilevel cross talk analysis and 3D visualization; and (v) novel inference of SNV effects on cell types, states, and functions at single-cell and spatial levels. LnCeVar 2.0 features a user-friendly interface for searching, browsing, and analyzing data. For instance, the CeVarState interface illustrates how SNV-ceRNA events influence cell states during developmental processes, revealing interactions that determine cell fate. The CeVarSC3D and CeVarST3D tools perform multilevel cross talk analyses of SNVs, ceRNA networks, and cell states in disease pathology, providing interactive 3D visualizations. Overall, we anticipate that the updated database will facilitate the high-resolution investigation of SNV-ceRNA networks and advance our understanding of the regulatory mechanisms in complex disease ecosystems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.